Thus, it is reasonable that FRAT1 has been found to be strikingly overexpressed in several human cancers, including esophageal cancer, cervical cancer, breast cancer, ovarian cancer, and non-small-cell lung cancer [7–11]. This evidence concerns the gene FRAT1 and breast carcinoma.